NCT02241187View on ClinicalTrials.gov

Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

September 12, 2014

Primary Completion Date

September 13, 2016

Study Completion Date

September 13, 2016

Conditions
Pancreatic Cancer
Interventions
DRUG

PEGPH20

DRUG

Cetuximab

DEVICE

DW & DCE-MRI

OTHER

blood draws

Blood samples will be drawn at various time points.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

Cold Spring Harbor Laboratory

OTHER

collaborator

Weizmann Institute of Science

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02241187 - Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection | Biotech Hunter | Biotech Hunter